NEU 0.26% $15.57 neuren pharmaceuticals limited

Share Price, page-8833

  1. 2,394 Posts.
    lightbulb Created with Sketch. 758
    Again, like others have said this is a small minded view imo.

    Jon has already said happy to go phase 3 in at least 1 indication, so clearly the dude that has more idea than anyone on here (and is hero-worshipped to-boot) thinks we can do that.

    The premise that we need to sell to deliver this to patients quickly is also flawed, as is the idea that licencing out indications we can't manage ourself to numerous parties is somehow messy or inefficient.

    Yeh the executuin risks of trying to be the next CSL are massive but CSL didn't get there with thinking like that.

    Yeh we need to hire more people, yeh we need to grow and change. Story of any stock that wants to grow to be a significant company.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.57
Change
-0.040(0.26%)
Mkt cap ! $1.990B
Open High Low Value Volume
$15.83 $15.87 $15.20 $8.124M 524.8K

Buyers (Bids)

No. Vol. Price($)
1 64 $15.49
 

Sellers (Offers)

Price($) Vol. No.
$15.58 597 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.